Patent · US Expired

Erythropoietin (EPO) peptides

US5106954A · kind A · utility

31Cited by

1References

5Claims

0Family size

Assignee

Behringwerke Aktiengesellschaft · DE

Inventors

Mathias Fibi · Marburg, DE
Werner Stuber · Lahntal, DE

Key dates

Filing date	Jul 24, 1990
Grant date	Apr 21, 1992
Priority date	—
Expiry date	Jul 24, 2010

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Erythropoietin (EPO) peptides and the use thereof for preparing epitope-specific anti-EPO antibodies are described. Also described are corresponding anti-EPO antibodies which take the form of polyclonal antibodies (antisera) or of monoclonal antibodies. These antibodies are suitable for purifying EPO, EPO derivatives or EPO peptides. The epitope-specific anti-EPO antibodies according to the invention can also be used for the detection of EPO and, in particular, for the epitope-specific detection of EPO. Additionally described are anti-idiotype antibodies which imitate a receptor region of EPO. Finally, pharmaceuticals which contain the said EPO peptides, anti-EPO antibodies or anti-idiotype antibodies, and diagnostic aids for the detection of EPO or of anti-EPO antibodies, are described.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.